CanadaBis Capital's subsidiary 1998643 AB LTD. ("Stigma Grow") secured its licence from Health Canada to sell cannabis cultivated at its 66,000 square foot cultivation facility in Red Deer, Alberta.
"By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry," the team with the company explains.
"We are thrilled to secure approval to begin selling our high-quality cannabis," said Travis McIntyre , CEO of CanadaBis Capital. "We are now perfectly positioned to grow and sell dry flower that will be among the highest potency available today, which is important when you consider what's lacking in the current market and what's needed to ensure the future of legal cannabis remains bright" said President & CEO, Travis McIntyre .
The Company anticipates a shift in consumer behaviour from a focus on dry flower to a focus on concentrates in 2020 and beyond. "To prepare for this demand, the Company has spent six months perfecting their systems and constructing a CIDI Lab to house hydrocarbon extraction processing — positioning them to bring difficult-to-produce products to market on a mass scale."
"We're just getting started! Stigma Grow intends to leverage our own top-quality flower, state-of-the-art technology, and the insight provided by our skilled and experienced staff, to target consumers and partner LPs looking for high-quality, 'bud-run' extract product variations", explains Travis. "Our vision as a company has always been to provide our community with what is in-demand, and all signs point to the need for consistent, high-potency concentrates."
While the Company awaits the final stages of their revised sales licence to include concentrates – they are actively stockpiling products to meet demands that will likely surpass supply for many years.
For more information:
CanadaBis Capital
530 8th Ave SW
Calgary, AB T2P 3S8
1-888-STI-GMA1
canadabis.com